# Neostigmine Methylsulfate

NDC: 63323-413
Generic name: Neostigmine Methylsulfate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20150108

FDA application: NDA203629

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-413"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-413
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0e11e4c-41c3-4874-b567-579db655fba3